Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

No evidence for linkage between the hereditary angiooedema clinical phenotype and the BDKR1, BDKR2, ACE or MBL2 gene

T. Freiberger, H. Grombiříková, B. Ravčuková, J. Jarkovský, P. Kuklínek, O. Kryštůfková, J. Hanzlíková, E. Daňková, O. Kopecký, R. Zachová, M. Lahodná, M. Vašáková, L. Grodecká, J. Litzman

. 2011 ; 74 (1) : 100-6.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12027761

Hereditary angiooedema (HAE) is a life-threatening disease with poor clinical phenotype correlation with its causal mutation in the C1 inhibitor (SERPING1) gene. It is characterized by substantial symptom variability even in affected members of the same family. Therefore, it is likely that genetic factors outside the SERPING1 gene have an influence on disease manifestation. In this study, functional polymorphisms in genes with a possible disease-modifying effect, B1 and B2 bradykinin receptors (BDKR1, BDKR2), angiotensin-converting enzyme (ACE) and mannose-binding lectin (MBL2), were analysed in 36 unrelated HAE patients. The same analysis was carried out in 69 HAE patients regardless of their familial relationship. No significant influence of the studied polymorphisms in the BDKR1, BDKR2, ACE and MBL2 genes on overall disease severity, localization and severity of particular attacks, frequency of oedema episodes or age of disease onset was detected in either group of patients. Other genetic and/or environmental factors should be considered to be responsible for HAE clinical variability in Caucasians.

000      
00000naa a2200000 a 4500
001      
bmc12027761
003      
CZ-PrNML
005      
20130508102230.0
007      
ta
008      
120817s2011 enk f 000 0#eng||
009      
AR
024    7_
$a 10.1111/j.1365-3083.2011.02547.x $2 doi
035    __
$a (PubMed)21375555
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Freiberger, Tomáš $7 xx0071641 $u Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic. tomas.freiberger@cktch.cz
245    10
$a No evidence for linkage between the hereditary angiooedema clinical phenotype and the BDKR1, BDKR2, ACE or MBL2 gene / $c T. Freiberger, H. Grombiříková, B. Ravčuková, J. Jarkovský, P. Kuklínek, O. Kryštůfková, J. Hanzlíková, E. Daňková, O. Kopecký, R. Zachová, M. Lahodná, M. Vašáková, L. Grodecká, J. Litzman
520    9_
$a Hereditary angiooedema (HAE) is a life-threatening disease with poor clinical phenotype correlation with its causal mutation in the C1 inhibitor (SERPING1) gene. It is characterized by substantial symptom variability even in affected members of the same family. Therefore, it is likely that genetic factors outside the SERPING1 gene have an influence on disease manifestation. In this study, functional polymorphisms in genes with a possible disease-modifying effect, B1 and B2 bradykinin receptors (BDKR1, BDKR2), angiotensin-converting enzyme (ACE) and mannose-binding lectin (MBL2), were analysed in 36 unrelated HAE patients. The same analysis was carried out in 69 HAE patients regardless of their familial relationship. No significant influence of the studied polymorphisms in the BDKR1, BDKR2, ACE and MBL2 genes on overall disease severity, localization and severity of particular attacks, frequency of oedema episodes or age of disease onset was detected in either group of patients. Other genetic and/or environmental factors should be considered to be responsible for HAE clinical variability in Caucasians.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a hereditární angioedémy $x genetika $x patofyziologie $7 D054179
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lektin vázající mannosu $x genetika $7 D037601
650    _2
$a lidé středního věku $7 D008875
650    _2
$a angiotensin konvertující enzym $x genetika $7 D007703
650    _2
$a fenotyp $7 D010641
650    _2
$a receptor bradykininu B1 $x genetika $7 D043783
650    _2
$a receptor bradykininu B2 $x genetika $7 D043782
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Grombiříková, Hana $7 xx0105241
700    1_
$a Ravčuková, Barbora $7 xx0105242
700    1_
$a Jarkovský, Jiří $7 stk2008461294
700    1_
$a Kuklínek, Pavel $7 xx0000490
700    1#
$a Kryštůfková, Olga. $7 xx0058260
700    1_
$a Hanzlíková, Jana $7 xx0064365
700    1_
$a Daňková, Eva, $d 1953- $7 xx0063661
700    1_
$a Kopecký, Otakar, $d 1955- $7 jn20000401408
700    1_
$a Zachová, Radana, $d 1962- $7 xx0118290
700    1#
$a Lahodná, Marie. $7 _AN068327
700    1_
$a Koziar Vašáková, Martina, $d 1964- $7 xx0104496
700    1_
$a Grodecká, Lucie $7 xx0142571
700    1_
$a Litzman, Jiří, $7 xx0000488 $d 1958-
773    0_
$w MED00010600 $t Scandinavian journal of immunology $x 1365-3083 $g Roč. 74, č. 1 (2011), s. 100-6
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21375555 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20130508102544 $b ABA008
999    __
$a ok $b bmc $g 949803 $s 785107
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 74 $c 1 $d 100-6 $i 1365-3083 $m Scandinavian journal of immunology $n Scand J Immunol $x MED00010600
LZP    __
$a Pubmed-20120817/11/03

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...